Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Scientific Reports|October 2, 2019
Targeted genomic CRISPR-Cas9 screen identifies MAP4K4 as essential for glioblastoma invasionLaura M Prolo, Amy Li, Scott F Owen, et al.Nature|April 5, 2019
CD22 blockade restores homeostatic microglial phagocytosis in ageing brainsJohn V Pluvinage, Michael S Haney, Benjamin A H Smith, et al.Cell Metabolism|September 12, 2023
Death-seq identifies regulators of cell death and senolytic therapiesAlex Colville, Jie-Yu Liu, Cristina Rodriguez-Mateo, et al.Elife|November 2, 2019
Retro-2 protects cells from ricin toxicity by inhibiting ASNA1-mediated ER targeting and insertion of tail-anchored proteinsDavid W Morgens, Charlene Chan, Andrew J Kane, et al.Nature Communications|September 8, 2019
Mitigation of off-target toxicity in CRISPR-Cas9 screens for essential non-coding elementsJosh Tycko, Michael Wainberg, Georgi K Marinov, et al.Neuron|October 8, 2019
CRISPR-Cas9 Screens Identify the RNA Helicase DDX3X as a Repressor of C9ORF72 (GGGGCC)n Repeat-Associated Non-AUG TranslationWeiwei Cheng, Shaopeng Wang, Zhe Zhang, et al.Biorxiv : the Preprint Server for Biology|June 19, 2024
CLCC1 promotes hepatic neutral lipid flux and nuclear pore complex assemblyAlyssa J Mathiowetz, Emily S Meymand, Kirandeep K Deol, et al.Blood Advances|April 10, 2024
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALLGaia Gentile, Teresa Poggio, Antonella Catalano, et al.Molecular Cell|November 6, 2020
Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression ProgramKathryn T Bieging-Rolett, Alyssa M Kaiser, David W Morgens, et al.Nature|August 17, 2017
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunityMarian L Burr, Christina E Sparbier, Yih-Chih Chan, et al.Pageof 5